Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 31.

Cavelti-Weder, C; Muggli, B; Keller, C; Babians-Brunner, A; Biason-Lauber, A; Donath, M Y; Schmid-Grendelmeier, P (2012). Successful use of Omalizumab in a inadequately controlled type 2 diabetic Patient with severe Insulin Allergy. Diabetes Care, 35(6):41.

Ellingsgaard, H; Hauselmann, I; Schuler, B; Habib, A M; Baggio, L L; Meier, D T; Eppler, E; Bouzakri, K; Wueest, S; Muller, Y D; Hansen, A M K; Reinecke, M; Konrad, D; Gassmann, M; Reimann, F; Halban, P A; Gromada, J; Drucker, D J; Gribble, F M; Ehses, J A; Donath, M Y (2011). Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nature Medicine, 17(11):1481-1489.

Traber, G; Baumgartner, M R; Schwarz, U; Pangalu, A; Donath, M Y; Landau, K (2011). Subacute bilateral visual loss in methylmalonic acidemia. Journal of Neuro-Ophthalmology, 31(4):344-346.

Mandrup-Poulsen, T; Pickersgill, L; Donath, M Y (2010). Blockade of interleukin 1 in type 1 diabetes mellitus. Nature Reviews. Endocrinology, 6(3):158-166.

Donath, M Y; Böni-Schnetzler, M; Ellingsgaard, H; Halban, P A; Ehses, J A (2010). Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends in Endocrinology and Metabolism, 21(5):261-267.

Wueest, S; Rapold, R A; Schumann, D M; Rytka, J M; Schildknecht, A; Nov, O; Chervonsky, A V; Rudich, A; Schoenle, E J; Donath, M Y; Konrad, D (2010). Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. Journal of Clinical Investigation, 34(1):191-201.

Dinarello, C A; Donath, M Y; Mandrup-Poulsen, T (2010). Role of IL-1beta in type 2 diabetes. Current Opinion in Endocrinology, Diabetes, and Obesity, 17(4):314-321.

Ehses, J A; Meier, D T; Wueest, S; Rytka, J; Boller, S; Wielinga, P Y; Schraenen, A; Lemaire, K; Debray, S; Van Lommel, L; Pospisilik, J A; Tschopp, O; Schultze, S M; Malipiero, U; Esterbauer, H; Ellingsgaard, H; Rütti, S; Schuit, F C; Lutz, T A; Böni-Schnetzler, M; Konrad, D; Donath, M Y (2010). Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet. Diabetologia, 53(8):1795-1806.

Lohmann, C; Schäfer, N; von Lukowicz, T; Sokrates Stein, M A S; Borén, J; Rütti, S; Wahli, W; Donath, M Y; Lüscher, T F; Matter, C M (2009). Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets. Atherosclerosis, 207(2):360-367.

Böni-Schnetzler, M; Boller, S; Debray, S; Bouzakri, K; Meier, D; Prazak, R; Kerr-Conte, J; Pattou, F; Ehses, J A; Schuit, F C; Donath, M Y (2009). Free Fatty Acids Induce a Proinflammatory Response in Islets via the Abundantly Expressed Interleukin-1 Receptor I. Endocrinology, 150(12):5218-5229.

Rütti, S; Ehses, J A; Sibler, R A; Prazak, R; Rohrer, L; Georgopoulos, S; Meier, D T; Niclauss, N; Berney, T; Donath, M Y; von Eckardstein, Arnold (2009). Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells. Endocrinology, 150(10):4521-4530.

Larsen, C M; Faulenbach, M; Vaag, A; Ehses, J A; Donath, M Y; Mandrup-Poulsen, T (2009). Sustained Effects of Interleukin-1-Receptor Antagonist Treatment in Type 2 Diabetes Mellitus. Diabetes Care, 32(9):1663-1668.

Ehses, J A; Lacraz, G; Giroix, M H; Schmidlin, F; Coulaud, J; Kassis, N; Irminger, J C; Kergoat, M; Portha, B; Homo-Delarche, F; Donath, M Y (2009). IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 106(3):13998-14003.

Zini, E; Osto, M; Franchini, M; Guscetti, F; Donath, M Y; Perren, A; Heller, R S; Linscheid, P; Bouwman, M; Ackermann, M; Lutz, T A; Reusch, C E (2009). Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat. Diabetologia, 52(2):336-346.

Donath, M Y; Böni-Schnetzler, M; Ellingsgaard, H; Ehses, J A (2009). Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes. Physiology, 24:325-331.

Parnaud, G; Hammar, E; Ribaux, P; Donath, M Y; Berney, T; Halban, P A (2009). Signaling pathways implicated in the stimulation of beta-cell proliferation by extracellular matrix. Molecular Endocrinology, 23(8):1264-1271.

Böni-Schnetzler, M; Ehses, J A; Faulenbach, M; Donath, M Y (2008). Insulitis in type 2 diabetes. Diabetes, Obesity and Metabolism, 10(Suppl.):201-204.

Ellingsgaard, H; Ehses, J A; Hammar, E B; Van Lommel, L; Quintens, R; Martens, G; Kerr-Conte, J; Pattou, F; Berney, T; Pipeleers, D; Halban, P A; Schuit, F C; Donath, M Y (2008). Interleukin-6 regulates pancreatic alpha-cell mass expansion. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 105(35):13163-13168.

Donath, M Y; Mandrup-Poulsen, T (2008). The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus. Nature Clinical Practice Endocrinology & Metabolism, 4(5):240-241.

Donath, M Y; Størling, J; Berchtold, L A; Billestrup, N; Mandrup-Poulsen, T (2008). Cytokines and beta-cell biology: from concept to clinical translation. Endocrine Reviews, 29(3):334-350.

Maedler, K; Schulthess, F T; Bielman, C; Berney, T; Bonny, C; Prentki, M; Donath, M Y; Roduit, R (2008). Glucose and leptin induce apoptosis in human beta-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases. FASEB Journal, 22(6):1905-1913.

Böni-Schnetzler, M; Thorne, J; Parnaud, G; Marselli, L; Ehses, J A; Kerr-Conte, J; Pattou, F; Halban, P A; Weir, G C; Donath, M Y (2008). Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. Journal of Clinical Endocrinology and Metabolism, 93(10):4065-4074.

Donath, M Y; Schumann, D M; Faulenbach, M; Ellingsgaard, H; Perren, A; Ehses, J A (2008). Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care, 31 Sup:S161-S164.

Ehses, J A; Böni-Schnetzler, M; Faulenbach, M; Donath, M Y (2008). Macrophages, cytokines and beta-cell death in Type 2 diabetes. Biochemical Society Transactions, 36(Pt 3):340-342.

Schwegler, B; Stumpe, K D M; Weishaupt, D; Strobel, K; Spinas, G A; von Schulthess, G K; Hodler, J; Böni, Thomas; Donath, M Y (2008). Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB. Journal of Internal Medicine, 263(1):99-106.

Ehses, J A; Perren, A; Eppler, E; Ribaux, P; Pospisilik, J A; Maor-Cahn, R; Gueripel, X; Ellingsgaard, H; Schneider, M K J; Biollaz, G; Fontana, A; Reinecke, M; Homo-Delarche, F; Donath, M Y (2007). Increased number of islet-associated macrophages in type 2 diabetes. Diabetes, 56(9):2356-2370.

Schumann, D M; Maedler, K; Franklin, I; Konrad, D; Størling, J; Böni-Schnetzler, M; Gjinovci, A; Kurrer, M O; Gauthier, B R; Bosco, D; Andres, A; Berney, T; Greter, M; Becher, B; Chervonsky, A V; Halban, P A; Mandrup-Poulsen, T; Wollheim, C B; Donath, M Y (2007). The Fas pathway is involved in pancreatic beta cell secretory function. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 104(8):2861-2866.

Donath, M Y; Ehses, J A; Maedler, K; Schumann, D M; Ellingsgaard, H; Eppler, E; Reinecke, M (2005). Mechanisms of beta-cell death in type 2 diabetes. Diabetes, 54(Suppl 2):S108-S113.

Mohanty, S; Spinas, G A; Maedler, K; Zuellig, R A; Lehmann, R; Donath, M Y; Trüb, T; Niessen, M (2005). Overexpression of IRS2 in isolated pancreatic islets causes proliferation and protects human beta-cells from hyperglycemia-induced apoptosis. Experimental Cell Research, 303(1):68-78.

Donath, M Y; Halban, P A (2004). Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia, 47(3):581-589.

Wiesli, P; Schäffler, E; Seifert, Burkhardt; Schmid, C; Donath, M Y (2004). Islets secretory capacity determines glucose homoeostasis in the face of insulin resistance. Swiss Medical Weekly, 134(37-38):559-564.

This list was generated on Tue Jun 18 15:25:28 2019 CEST.